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Objective:  Health  data  constitute  a signiﬁcant  resource  in  most  OECD  countries  that  could be
used to improve  health  system  performance.  Well-intended  policies  to allay  concerns  about
breaches  of conﬁdentiality  and  to  reduce  potential  misuse  of  personal  health  information
may  be limiting  data  use.  A survey  of  20 OECD  countries  explored  the  extent  to  which
countries  have  developed  and  use  personal  health  data  and  the reasons  why  data use  may
be problematic  in some.
Results:  Countries  are  divided,  with  one-half  engaged  regularly  in  national  data  linkage
studies  to monitor  health  care  quality.  Country  variation  is linked  to risk  management  in
granting  an exemption  to patient  consent  requirements;  in sharing  identiﬁable  data  among
government  authorities;  and  in  project  approvals  and granting  access  to  data. The  resources
required  to  comply  with  data  protection  requirements  is  a secondary  problem.  The  sharing
of person-level  data  across  borders  for international  comparisons  is rarely  reported  and
there were  few  examples  of  studies  of health  system  performance.
Discussion:  Laws  and  policies  enabling  data  sharing  and  data  linkage  are  needed to
strengthen  national  information  infrastructure.  To  develop  international  studies  compar-
ing health  care  quality  and health  system  performance,  actions  are  needed  to  address
heterogeneity  in  data  protection  practices.
hors. P© 2013 The Aut
. Introduction
Health data constitute a signiﬁcant resource in most
ECD countries and it makes economic and ethical sense
o use these data as much as possible to improve the effec-
iveness, safety and patient-centeredness of health care
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systems. Regional, national and international reports on
health and health care are entirely dependent upon moni-
toring policies and investments in data infrastructure that
either facilitate or restrict data and analysis [1].
Understanding the quality of health care and the per-
formance of health care systems requires the ability to
monitor the same individuals over time, as they experi-
ence health care events, receive treatments, experience
improvements or deteriorations in their health and live or
die. It also requires understanding the distribution of health
and health outcomes across different groups in the pop-
ulation and understanding variations in care quality and
Open access under CC BY-NC-SA license.health outcomes.
This work has a few, very important, prerequisites. First
it depends on the collection and storage of data at the level
of individual patients (for an entire population of patients
r CC BY-NC-SA license.
alth Poli
vey that national datasets with individual-level records
are available across the spectrum of health care admin-
istration, as well as from population health surveys and
1 Members of the Health Care Quality Indicators Expert Group represent
the 34 member countries of the Organisation for Economic Cooperation
and Development as well as a number of non-member countries who are
participating actively in the HCQI project.
2 The countries were Australia, Belgium, Canada, Cyprus, Denmark,
Finland, France, Germany, Italy, Japan, Korea, Singapore, Sweden,10 J. Oderkirk et al. / He
or for a representative sample). The most common sources
of health data are registries, administrative data, popula-
tion surveys, patient surveys and clinical records. Second,
it relies on the capacity to follow individual patients across
the care continuum and through different health and
health care events to measure change. Following patients
through different events often requires the linkage of
patient records across datasets. These data can then be
used to reduce unsafe practices, to improve guidance to
clinicians on the most appropriate care and to make good
decisions about the wise use of health care resources.
On 7–8 October 2010, Health Ministers from OECD
countries met  in Paris to discuss how to improve value
in health care. In their ﬁnal communiqué, they underlined
the importance of better health information systems [2].
They called for more and effective use of health data that
has already been collected. They also recognised the need
to reconcile the legitimate concerns of citizens to protect
their privacy with the use of health data to improve health
system performance and the quality of care.
In the development of the OECD programme of health
care quality indicator reporting, there was evidence of sig-
niﬁcant cross-country variability in the extent to which
health data resources were being used to monitor and
improve health care quality [1]. Well-intended privacy
and conﬁdentiality decisions, which aim to allay concerns
about breaches of conﬁdentiality and reduce potential mis-
use of personal health information, may  have made a
contribution to this variation.
In 2008, the Working Group on Data Protection of
the EU NCA observed that diverging opinions on how
to interpret the EU Data Protection Directive (Directive
95/46/EC) and poor transposition into national data
protection laws appeared to be a signiﬁcant barrier for
European public health monitoring and research [3]. The
group recommended that best practice examples should
be developed to provide guidance on the collection of high
quality health data and that the privacy requirements
be clariﬁed and harmonised across countries. Further,
the group concluded that awareness of data protection
issues among public health experts and researchers should
also be promoted. Many other individuals and groups
– especially medical researchers, public health ofﬁcials,
and health care delivery organisations – have countered
that overzealous or misdirected privacy protections are
thwarting efforts to use information to improve patient
care and public health [4–8].
2. Methods
In 2011/12, the OECD undertook a study to better under-
stand the challenges, the opportunities and the practices
in the use of data to monitor and describe pathways of
care and health care outcomes to enable health care quality
and health system performance monitoring and research
[9]. A mail-back questionnaire sought information about
the general environment in each country for the secondary
use of personal health data as well as speciﬁc case studies.
The questionnaire was sent to the members of the OECDcy 112 (2013) 9– 18
Health Care Quality Indicators Expert Group1 in July 2011
who  were each responsible for coordinating a response on
behalf of their country. Responses were received from 20
countries from September 2011 through to March 2012.
Questions identiﬁed national datasets of personal health
information; the availability of patient identiﬁers; the con-
duct and regularity of data linkage studies; the focus of
data linkage studies; the use of linked data for health
care quality monitoring or research; restrictions to data
linkage projects and views about the potential for data
linkage activities within the next ﬁve years. The survey
also asked about regional/state level datasets and health
care organisation datasets and their use in data linkage
studies. Countries participating in the survey included
Australia, Belgium, Canada, Cyprus, Denmark, Finland,
France, Germany, Israel, Japan, Republic of Korea, Malta,
Norway, Poland, Portugal, Singapore, Sweden, Switzerland,
the United Kingdom and the United States.
This survey also asked ofﬁcials to identify government
experts knowledgeable about the general environment for
secondary use of personal health data and national data
privacy protection legislations and to identify the leaders
of two  national projects involving the linkage of health
administrative or clinical data that have taken place within
the past ﬁve years and one multi-country study. If there
were no national projects, then sub-national projects could
be reported. Structured telephone interviews were then
conducted with 1–5 experts in each of 16 countries from
September 2011 to March 2012 about legislative require-
ments and practices for data privacy protection including
project approval processes, data linkage, data sharing, data
security and data access modalities.2 Written summaries
were provided to interview participants for veriﬁcation.
Responses to the OECD country survey and the telephone
interviews were consolidated into an OECD report that was
reviewed by countries’ health ofﬁcials in both 2012 and
2013 and revised to reﬂect country comments [9].
3. Results
3.1. Information infrastructure for data linkage appears
strong
There is a strong underlying infrastructure for analysis
of personal health data within the countries participating
in this study (Table 1). Most reported to the OECD sur-Switzerland, the United Kingdom and the United States. All participants
are  identiﬁed in Annex B of the report Strengthening Health Informa-
tion Infrastructure for Health Care Quality Governance: Good Practices, New
Opportunities and Data Privacy Protection Challenges [9]. Italy identiﬁed
respondents to participate in the telephone interview, but did not submit
a  response to the OECD country survey.
J. Oderkirk et al. / Health Poli
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registries/censuses. In such datasets, each row of the
dataset represents an individual patient or person.
To follow patients through the care pathway, and thus
from one dataset to another, identifying variables are also
required. Many countries have a unique patient identify-
ing number or UPI available for patients or persons within
national hospital in-patient, primary care, cancer registry,
prescription medicines and mortality datasets (Table 1).
A greater number of countries reported other identifying
variables, such as names, dates and addresses that may  also
be used to enable data linkages.
In Australia, Canada, Germany, Israel, Portugal, Sweden,
and the United States, the health information infrastructure
for data linkage was  reported to be stronger or more devel-
oped sub-nationally, at the regional/state/provincial level
or within networks of health care organisations.
3.2. From data to evidence for health system
improvement
There were several examples provided by respondents
to the OECD country survey of the linkage of personal
health data to follow the pathway of care and evaluate the
quality and effectiveness of health care treatments. The
PERFECT study [10,11] in Finland monitors the content,
quality and cost-effectiveness of treatment episodes in spe-
cialised medical care and thus contributes to monitoring
health-system performance. Indicators and models were
created to monitor the whole cycle of care and outcomes
for disease groups and procedures (stroke, premature new-
borns, hip fracture, breast cancer, schizophrenia, acute
myocardial infarction, and orthopaedic endoprosthesis
including hip and knee replacement surgery, and invasive
heart surgery). Results have contributed to changes in law
and government policy and have been used within hospi-
tals to improve the quality of care [12].
The Republic of Korea’s quality assessment of medical
services includes assessment of the clinical appropriate-
ness and cost effectiveness of health care by reporting on
quality and inducing service providers to make improve-
ments in response to the evidence [13]. Indicators include
30-day case fatality for acute myocardial infarction; 30-
day post-operative mortality for major types of surgery;
hospital re-admissions for mental-health patients; pre-
scribing patterns and outcomes in primary care; and health
outcomes of prescribing to mental-health patients. The
program aims to identify underuse, overuse and misuse of
therapies and to reduce variation in care practices through
the regular reporting of quality indicators. There are also
quality and efﬁciency assessments of clinical care guide-
lines in Sweden [14]. For areas of care subject to national
guidelines, such as cardiac and stroke care, data link-
ages are undertaken to develop indicators to evaluate the
effectiveness of recommended therapies and the evidence
contributes to revisions of the care guidelines.
In Germany there are projects to evaluate the effec-
tiveness and safety of breast cancer screening [15]. A new
follow-up of both women who participated in a clinical
trial involving screening and those who  were unscreened
will assess the beneﬁts and potential adverse effects of
exposure to mammography screening to provide evidence
alth Poli
formal long-term care remain relatively rare, with only 4–5
countries reporting undertaking such work with national
datasets.12 J. Oderkirk et al. / He
to develop early detection guidelines for mammography
screening. Belgium also has several studies underway
where data linkages are generating new information about
quality of care and outcomes for cancer patients [16,17].
Israel is linking data to examine quality of care for colon
surgery patients by measuring post-operative infections,
re-hospitalisations and deaths. Israel has also explored
mortality among psychiatric patients in order to improve
community mental health care [18].
Data linkage projects in the United Kingdom were ini-
tiated to overcome gaps in existing information to provide
a more comprehensive and consistent picture of maternity
outcomes [19,20]. England monitors hospital standardised
mortality ratios that will be replaced, in future, with a sum-
mary hospital-level mortality indicator. England produces
a 30-day post-operative mortality rates for patients fol-
lowing colorectal cancer surgery. Scotland reports using
linkage to monitor readmissions and deaths among coro-
nary heart disease patients.
Australia has explored care transitions for older peo-
ple with chronic health conditions including the factors
inﬂuencing pathways and, particularly the entry into resi-
dential care [21]. A new study in Australia is investigating
the health effects of exposure to low-dose radiation from
CT scans in childhood. To extend the information available
about pathways of stroke care beyond the acute care set-
ting, a pilot data linkage project is underway in Canada
[22]. Denmark is exploring wait times in cancer treatment
pathways.
Singapore reports a national program to monitor the
quality of primary care for chronic disease management
by examining health care providers’ adherence to rec-
ommended care processes as well as their success in
preventing hospitalisations related to chronic conditions
[23].
3.3. Building foundational platforms to support health
system performance research
There are also initiatives underway to build a ﬁrmer
foundation upon which studies of health system perfor-
mance may  be based. To monitor and study health care
consumption and expenditures to inform policy decisions,
Belgium and France have developed a permanent sam-
ple of socially insured persons via the linkage of health
care reimbursement invoice data to create longitudinal his-
tories of health care encounters [24,25]. In Switzerland,
a linkage of population census data and mortality data
is enabling a better understanding of the socio-economic
and socio-demographic characteristics of mortality and life
expectancy and forms a base cohort from which additional
data may  be linked for speciﬁc, approved, studies, such as
socio-demographic differences in cancer survivorship and
outcomes [26].
In the United States, the National Center for Health
Statistics has built a platform to support health and health
services studies, including a repository of surveys that have
been prepared to support linkage projects and two  key
linkages: the linkage of population health survey data to
mortality data; and the linkage of population health sur-
vey data to data on health care encounters for Medicarecy 112 (2013) 9– 18
and Medicaid insurance beneﬁciaries [27]. In the United
Kingdom, there is a national initiative to support health
care quality improvement by facilitating research involv-
ing personal health data that are in the public’s interest.
The service can both produce tabulations and conduct data
linkages on behalf of clients with approved projects [28].
In Australia, the Population Health Research Network, with
funding from the Australian Government, is building infra-
structure for record linkage in all states and territories and
also at the national level in order to improve the way data
are exchanged and accessed [29].
3.4. Country variation in the decision to regularly
undertake data linkage studies
Data linkages often depend on the sharing of data
across authorities in custody of data and require the amal-
gamation of patient-level information from two or more
distinct datasets. Both the sharing and the linkage of data
place risks on the protection of the privacy of the per-
sons whose data are involved. Table 2 presents results of
the OECD country survey regarding the variability across
countries in the use of personal health data for regular
health and health care monitoring requiring data linkages.3
Seven countries involve many national datasets in data
linkage projects on a regular basis. In all but one of these
countries, a unique patient identifying number is available
to facilitate the linkages (Table 2). The United States relies
more on sets of patient identifying information, such as
names, dates and addresses, to establish links. Australia,
Belgium, France, and Switzerland also undertake projects
involving the linkage of several datasets on a regular basis.
Belgium has a greater ability to conduct these linkages
using a unique patient identifying number, while other
identiﬁers are more often used in Australia. France is chal-
lenged in data linkages due to the use of two  different
patient UPIs across its key datasets.
Canada, Malta and Norway conduct regular data linkage
projects with some datasets and use a unique identify-
ing number to undertake the work. Cyprus, Portugal and
Singapore have national datasets with patient identifying
numbers and/or other patient identiﬁers, but engage in
data linkage on a regular basis with only two  of the avail-
able datasets. Germany, Switzerland, Japan and Poland all
have national datasets with variables that could be used to
undertake data linkage projects, but none do so regularly.
Just over half of countries reported regularly monitoring
health care quality through the linkage of their hospital in-
patient, cancer registry, and mortality data and less than
half of countries with their prescription medicines data
(Table 1). Regular linkage studies to monitor the quality
of primary health care, mental hospital in-patient care and3 Further description of these data linkages is provided in chapters 2
and 3 of the OECD report Strengthening Health Information Infrastructure
for  Health Care Quality Governance: Good Practices, New Opportunities and
Data Privacy Protection Challenges [9].
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Table 2
Distribution of the regular occurrence of health-related record linkage projects by availability of datasets with patient identiﬁers.
Most national data with a
unique patient identifying
number (UPI)
Most national data with
other patient identiﬁers
Some national data with a
unique patient identifying
number (UPI)
Data linkage projects on a regular basisa with. . .
7+ national datasets Denmark, Finland, Israel,
Korea, Sweden, United
Kingdom
United States
5–6  national datasets France, Belgium Australia Switzerland
3–4  national datasets Canada, Malta, Norway
2 national datasets Singapore Cyprus, Portugal
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a Regular basis was deﬁned as a record linkage study using this dataset
.5. Country variation linked to differences in risk
anagement in the decision process
Risk management in any decision-making process
nvolves identifying the risks and evaluating their poten-
ial costs and beneﬁts [30]. It does not imply avoiding all
isks, but making an informed decision under uncertainty.
ncertainty is unavoidable in decision-making about the
ollection and use of personal health data. Nonetheless,
voiding or delaying decision-making carries its own  risks,
n terms of compromising patient safety and the quality of
ealth care. The core challenge is for countries to identify
nd weigh the tradeoffs among data risks and data utilities.
his balance is reﬂected in Fig. 1 as the point where best
ractices in data collection, linkage and analysis are identi-
ed and implemented, providing the optimum risk/return
rade-off. This trade-off will be speciﬁc to the context of
ndividual countries.
This OECD study revealed three key areas where signiﬁ-
ant cross country differences in the use of personal health
ata could be attributable to differences in risk manage-
ent: use of personal health data when obtaining patient
onsent is impossible or cost prohibitive; sharing of identi-
able personal health data among government authorities,
nd approval of projects involving the linkage of personal
ealth data. The resources required to comply with leg-
slative and policy requirements to enable data linkages
s a secondary problem, as is the cost of developing the
echnical capacity to undertake the work.
.6. Use of patient data when patient consent is
mpossible or cost prohibitive
Informed consent has become the pillar for protec-
ing individual’s autonomy where research involves human
ubjects. Informed consent requirements in legislation
uild from professional codes of practice. Informed con-
ent presumes the ability to indicate clearly to a participant
he use and the purpose of a particular research activity
31]. This is feasible for a purpose-speciﬁc study, such as
n invitation to patients to participate in a clinical trial or
 survey.
The requirement to obtain patient consent presents sig-
iﬁcant challenges, however, for health and health care
onitoring and research involving large, historical popu-
ation and patient datasets. These datasets were originallyPoland, Germany
lly underway.
collected for other purposes, such as administering the
health system or providing clinical care and represent
hundreds of thousands to millions of persons. The retro-
spective collection of patient consent implies that useable
data will be biased towards non-movers and health-
ier/younger patients, which can compromise the validity
and the utility of the ﬁndings. Further, attempting to reach
large cohorts can be impractical and requires, often signif-
icant, ﬁnancial resources.
This OECD study found considerable variability across
countries in responding to the problems involved in retro-
spective patient consent for studies requiring the linkage of
patient records among historical and large personal health
datasets. While some allow for exemptions to patient con-
sent requirements for projects in the public interest, others
do not.
While providing a unifying framework, the EU Data
Protection Directive (Directive 95/46/EC) left considerable
freedom to EU countries regarding whether to apply,
restrict or extend the rules on processing sensitive data.
Experts in several European countries indicated that
approval to use the data without patient consent would be
granted at the level of the national data protection ofﬁce
and that it is very difﬁcult to obtain approval without ﬁrst
introducing authorising legislation for the project itself
(Belgium, Italy, and Cyprus). Experts in Germany noted that
personal health data may  only be used with patient consent
or when authorised by law or regulation. Further, new leg-
islation authorising a project may  be required at the state
level, depending on the data involved. Portugal reported to
the OECD country survey that record linkage is illegal in the
absence of authorising legislation. Poland reported to the
country survey that it has not established a legal basis for
national data linkages and has no reportable national data
linkage projects.
Experts from other European countries (France,
Sweden, Denmark, Finland and the United Kingdom)
indicated that their data protection legislation sets out
the framework within which identiﬁable data may  be
processed without informed consent. In these countries,
decision-making on individual projects may  be delegated
to data custodians or to national approval bodies who
weigh the risk trade-off between individual privacy and
monitoring and research that is in the public’s interest.
Experts in other federated countries, such as the United
States, Canada, and Australia reported a complex web of
14 J. Oderkirk et al. / Health Policy 112 (2013) 9– 18
lth data Fig. 1. Continuum of risk in the decision to share and to link personal hea
legislations at the level of the nation, states/provinces,
and local areas. In general, national data custodians in
these countries may  have their role incorporated within
legislation that then enables them to set up an inter-
nal process for decision-making for individual projects. In
Australia, guidelines issued by the National Health and
Medical Research Council [32] provide a framework for
the conduct of medical research using information held
by Commonwealth agencies where identiﬁed information
needs to be used without consent. Approval of projects
must be obtained through a Human Research Ethics Com-
mittee.
Experts from the Republic of Korea and Singapore
reported legislative frameworks that set out conditions
where public data custodians may  process personal health
data without consent. Experts from Japan, on the other
hand, reported that Japan has not established a legal basis
for national data linkages and has no reportable national
data linkage projects.
3.7. Sharing of identiﬁable personal health data among
government authorities
Datasets of key health information may  be in the cus-
tody of various actors within countries. Each of these
custodians has the authority necessary to collect, analyse
and disseminate information for monitoring health and
health care and play a critical role in decisions about datafor health care quality and system performance monitoring and research.
use. The OECD country survey found that all countries
reported that there are several national governmental
authorities, agencies or organisations acting as custodians
of their key national person-level datasets. The only excep-
tion was  Switzerland, where the key datasets identiﬁed
in this survey were all under the custody of the Federal
Statistical Ofﬁce. Thirteen countries reported having 70%
or more of their national datasets in the custody of two
national organisations, typically the health ministry and
the statistical ministry; while in the other seven countries,
data were less centralised. Commonly reported custodi-
ans included government ministries, insurers, agencies,
research institutes, and registries. In some countries, cus-
todianship of certain key datasets for national projects is
at a sub-national level (such as in the United Kingdom,
Australia, Canada, Italy, and Germany). Where there are
multiple data custodians, there must also be legal frame-
works and information custodian policy frameworks that
provide for the possibility of sharing identiﬁable personal
health data.
Several country experts interviewed described difﬁ-
culties in negotiating data sharing arrangements among
government ministries, where negotiations were either
unsuccessful or it took years to negotiate agreement. Con-
cerns about legislative barriers hindering the sharing of
identiﬁable personal health data were signalled by experts
interviewed from Cyprus and Italy and were reported to
the OECD country survey by Poland and Portugal. Lengthy
alth Poli
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nd complex processes to reach agreement for data shar-
ng among public authorities were reported by experts
nterviewed from the United States, Canada, Australia and
ermany.
.8. Approval of data linkage studies
In all countries where governments engage in link-
ges of personal health data, experts interviewed described
rocesses to consider approval of data linkage projects
roposed by researchers within and outside of govern-
ent, such as academic researchers. There are variations
cross countries in the decision-making authority for
rojects. Some country experts indicated that the decision
o approve the use of personal health data for a data linkage
roject would be made at the level of the data custodian
Australia, Canada, Singapore, Finland, Sweden, United
ingdom (Scotland) and the United States). A smaller num-
er of country experts noted that the approval of data
inkage projects was delegated to a national authority. In
elgium, Finland and Denmark, experts explained that the
ational data protection authority approves data linkage
rojects proposed by government ministries and by pri-
ate entities. In the United Kingdom (England and Wales),
xperts explained that the National Information and Gov-
rnance Board approved projects to be undertaken in the
ublic sector and by private entities where the use of
ersonal data is not authorised by law and where the con-
ent of data subjects was not obtained. Since April 2013,
owever, these responsibilities have passed to the Health
esearch Authority [33].
In some countries with decentralised administration of
ealth, and therefore data custodians at the sub-national
evel, experts described decentralised decision-making on
he approval of projects involving personal health data
Australia, Canada, Germany, Italy and the United States).
or example, in Australia, an expert explained that there
re efforts underway to permit data collected and linked at
he state level to be amalgamated at the national level, cre-
ting the potential for analysis and reporting at a national
evel and also for data linkage projects with national data
n the custody of the Australian Institute for Health and
elfare. The project is challenging because legislation and
overnance vary across the Australian states.
.9. Use of personal health data in multi-country projects
Multi-country studies can provide a rich source of
nformation for the beneﬁt of the public’s health and the
anagement of health systems. Multi-country projects
lso pose challenges for data protection, as the data cus-
odians involved typically have no legal recourse to exert
ny penalties for misuse of data by a foreign entity. Multi-
ountry projects are also difﬁcult for research teams to
mplement, as the data protection requirements of each
articipating data custodian must be respected.
Some EU country experts interviewed noted that their
ata protection legislations make it possible to share iden-
iﬁable data with another EU country. Respondents from
he U.K. and France also noted that non-EU countries
an be reviewed for equivalency of their data protectioncy 112 (2013) 9– 18 15
legislative framework to that of the EU in order to also
qualify to share data. Nonetheless, few European country
experts reported engaging in projects where de-identiﬁed
micro data were shared across borders. Denmark’s National
Board of Health has contributed de-identiﬁed individual
data to multi-country studies with other Scandinavian
countries.
Outside of Europe, there were also few possibilities
reported. Experts from the United States National Cen-
tre for Health Statistics expressed that they can provide a
foreign researcher with access to de-identiﬁed individual-
level data, however, the process of de-identiﬁcation is very
strict and not all data can be de-identiﬁed.
There were examples provided by countries responding
to the OECD survey of parallel studies where researchers
within several countries each independently conducted
analysis of linked personal health data following a com-
mon  study protocol [34–37]. Most of these studies were
related to cancer treatment outcomes and survivorship.
The European Health Care Outcomes, Performance and Efﬁ-
ciency project (EuroHOPE) stands out as it aims to evaluate
the performance of European health care systems in terms
of outcomes, quality use of resources and costs through
the linkage of hospital, pharmaceutical, cancer registration
and mortality datasets and the EUropean Best Information
through Regional Outcomes in Diabetes (EUBIROD) project
stands out as it aims to implement a sustainable European
diabetes register [38,39].
EuroHOPE is limited to six European countries that all
had the health information infrastructure and legal frame-
works necessary to enable the data linkages. While diabetes
registries are available across Europe, EUBIROD was  chal-
lenged to ﬁnd common ground where local requirements
for data security and privacy were respected [40,41]. The
EUBIROD team concluded that the sharing of de-identiﬁed
micro data would not be possible for their project without
limiting the participation in the registry to a small number
of countries. The solution was  the development of a sys-
tem where each diabetes registry could submit aggregated
information with very little re-identiﬁcation risk.
3.10. Resource constraints and options to improve
efﬁciency in meeting data protection requirements
In many countries, experts interviewed indicated that
data custodians are responsible for vetting project pro-
posals for the use of data from government and private
entities; maintaining a technical capacity to undertake data
linkages and to de-identify data; providing data access
modalities to internal and external researchers; and ensur-
ing that through all of their activities the legal requirements
for data security and data privacy protection are respected.
Experts from several countries noted that fulﬁlling these
responsibilities is expensive and that pressure is mount-
ing to trim expenditure. Further, expenses are particularly
heavy in countries with decentralised administration of the
health system. In these countries, data custodians at sub-
national levels are also carrying out these responsibilities.
In all countries participating in the study, experts
indicated that data security and the protection of data
conﬁdentiality are given considerable attention by data
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custodians. It was common for experts to report that their
institution’s existence or its ability to continue its pro-
gramme  of work would be placed at risk by a serious breach
of data security. Nonetheless there is variation across data
custodians in the data security measures that have been put
into place. Challenging areas reported by experts included
ﬁnding acceptable mechanisms to de-identify data, so that
it can be accessed and used for monitoring and research
and still protect privacy; and ﬁnding appropriately safe
mechanisms to give government researchers and academic
researchers access to the data. At one end of the spectrum,
there are custodians who reported managing their risk by
refusing to provide access to data for research and moni-
toring to be undertaken by another government ministry or
an academic researcher. On the other end of the spectrum,
there are custodians who reported that identiﬁable per-
sonal health data may  be shared with external researchers.
A few country experts provided interesting examples
of centralising the difﬁcult tasks of linking data, de-
identifying data, approving access to data and supervising
access to data. In the United Kingdom [42,43], Belgium
[44,45], Australia [46], Korea [47], Canada [48] and Finland,
trusted third parties have been engaged to conduct data
linkages and to de-identify linked data for use by gov-
ernment and external researchers. The development of
dedicated linkage centres is a strategy that could be fur-
ther explored to both enhance and standardise data privacy
protection and to reduce costs otherwise born by individ-
ual data custodians. The United States [49], Canada [50]
and Singapore have established secure supervised facili-
ties where researchers can access de-identiﬁed data that
carries a higher re-identiﬁcation risk. Experts from the
United States [51] and Australia [52] also reported hav-
ing established a secure remote data access option for
researchers where they may  submit programmes to ana-
lyse de-identiﬁed data and receive outputs. Canada is
piloting this approach [53] and such an approach is part
of a new initiative in the United Kingdom (Scotland) [54].
4. Discussion
The availability of person-level data across the health
care continuum, with unique patient identiﬁers, provides
a foundation upon which programs of health system per-
formance monitoring and research with this data may
be developed across OECD countries. There are signiﬁ-
cant challenges to overcome, however, before all countries
can realise the beneﬁts from analysis of their information
resources.
Some countries have not built a legislative framework
or a policy framework for data protection that offers the
possibility for an exemption to the requirement of patient
consent for projects in the public’s interest. The conse-
quence of managing risk to individual’s data privacy by
requiring re-contact to obtain patient consent from large
population cohorts or requiring a new legislation to be
passed to authorise a project where re-contact is not
practical; is that it is very unlikely that there will be com-
prehensive and evolving programs of health and health
care quality monitoring that beneﬁt from the countries’
existing information assets.cy 112 (2013) 9– 18
Another key element of this issue involves deﬁning
what constitutes acceptable patient consent as countries
move forward to collect new population health and health
care administrative data that may  be used for future health
and health-care monitoring and research. More generalised
patient consent approaches would enable a broader range
of future monitoring and research.
Many countries with weaker health information
infrastructure for data linkages have decentralised the
administration of health systems and have not reached a
consensus within the country of how the levels of gov-
ernment could work together. Data from decentralised
systems must be brought together to support national
information infrastructure and capacity for data linkages
at the level of the country. When data-sharing agreements
take years to negotiate or cannot be negotiated, there will
be considerably fewer initiatives to monitor and report on
health and health care quality requiring data linkages.
If, as a result of a lack of centralisation, government min-
istries and private entities must seek approval from many
different data custodians to conduct one project, it will be
very difﬁcult to undertake a national project involving the
use of personal health data. Data custodians are challenged
in meeting all of the requirements of data protection legis-
lations and policies, due to resource constraints and a lack
of recognised best practices in difﬁcult areas such as data
de-identiﬁcation processes, and secure data access modal-
ities. Further complicating the approval process are factors
such as inconsistent or unavailable communication from
data custodians on the process to seek approval, on the
requirements of an applicant, or on the access modalities
that are possible.
New forms of centralised approaches to project pro-
posal review and data linkage services are very interesting
developments. Not only do these help to standardise
requirements and practices for both the government and
external researchers, they have the potential to be more
efﬁcient.
Managing risk is clearly difﬁcult in the area of multi-
country projects and there has been little progress. The
beneﬁt of developing legal and practical mechanisms to
enable multi-country projects to proceed in a manner that
minimises risks to the privacy of personal health data
would be to promote improvement across OECD countries
in patient safety and health system performance. Further,
it is very difﬁcult to understand and uncover data qual-
ity problems in international data comparisons when the
underlying data cannot be viewed or evaluated.
A role for the OECD in the coming years is to
continue to support countries in reaching the goal of
strengthening health information infrastructure so that
privacy-respectful uses of data for health, health care
quality and health system performance monitoring and
research become widespread, regular activities. Further,
the OECD can contribute to assuring that national health
information infrastructure becomes better capable of
supporting multi-country monitoring and multi-country
research.
On-going monitoring of the development of health
information infrastructure will help to promote shared
learning about advancements and challenges in the
alth Poli
d
c
o
p
p
r
f
o
i
t
o
i
t
m
e
e
c
t
a
a
s
n
c
t
w
r
D
A
u
E
m
t
c
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[J. Oderkirk et al. / He
evelopment and use of health data; promote international
omparability of data and data linkages; and uncover new
pportunities for the development of internationally com-
arable indicators of the quality of care and health system
erformance.
Another important step will be to support countries in
educing unnecessary obstacles to data use that can arise
rom differences in legislations regarding the protection
f health information privacy and/or differences in the
nterpretation of what is necessary and helpful to assure
hat patients’ privacy rights are respected in the conduct
f health monitoring and research. The OECD is working
n 2013/14 to classify data uses according to their risk
o patient’s information privacy and to associate recom-
ended data privacy protection practices that can enable,
ven very sensitive data, to be used safely.
Further international action is needed to address het-
rogeneity in privacy protections in order to support all
ountries in developing regular, privacy-respectful, sta-
istical and research uses of data and to promote the
dvancement of internationally comparative indicators
nd evidence to improve health care quality and health
ystem performance. This effort is particularly important
ow as there are legislative reforms on the horizon in many
ountries, including a new EU Data Protection Regulation
o be translated into legislation within EU member states,
hich have the potential to enable or restrict statistics and
esearch over the next decade.
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